Biological Treatment 2026 I Tender in Czech Republic - 142834300

Procurement Summary

Country: Czech Republic

Summary: Biological Treatment 2026 I

Deadline: 07 Jul 2026

Posting Date: 08 Jun 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 142834300

Document Ref. No.: 388612-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: CZK 6833220.32

CPV Classification

33661000 - Medicinal products for the nervous system
33673000 - Medicinal products for obstructive airway diseases

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Dimethyl fumarate (ATC L04AX07) IV. Omalizumab (ATC R03DX05) III. Nintedanib (ATC L01EX09) II. Glatiramer Acetate (ATC L03AX13) The subject of the public contract is the continuous supply of medicinal products for biological treatment in the scope according to the needs of the contracting authority. Public the order is divided into 4 parts according to the active substances. More detailed specifications are given in Annex No. 3.1 - 3.4 of the tender documentation - Price offer. Doc Title: Biological treatment 2026 I Contract Type: supplies
Document Type: Contract Notice Reference Number: 26031 Contract Type: supplies Estimated Value: 6833220.32 - CZK Authority Type: body-pl-cga Doc Title: Biologická léčba 2026 I Dispatch Date: 2026-06-05 Publish Date: 2026-06-08 Submission Date: 2026-07-07

Documents

 Tender Notice